Related references
Note: Only part of the references are listed.Low-dose metformin targets the lysosomal AMPK pathway through PEN2
Teng Ma et al.
NATURE (2022)
Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite-binding site
Matthew J. Sanders et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Inhibition of basal and glucagon-induced hepatic glucose production by 991 and other pharmacological AMPK activators
Manuel Johanns et al.
BIOCHEMICAL JOURNAL (2022)
When insulin isn't enough: targeting glucagon in type 1 diabetes
Michelle Van Name et al.
NATURE MEDICINE (2022)
Hernandezine, a natural herbal alkaloid, ameliorates type 2 diabetes by activating AMPK in two mouse models
Jing Bai et al.
PHYTOMEDICINE (2022)
Exercise induces tissue hypoxia and HIF-1α redistribution in the small intestine
Die Wu et al.
JOURNAL OF SPORT AND HEALTH SCIENCE (2020)
AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control
Asier Gonzalez et al.
CELL METABOLISM (2020)
Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation
Tabassum Moonira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Long-chain fatty acyl-CoA esters regulate metabolism via allosteric control of AMPK β1 isoforms
Stephen L. Pinkosky et al.
NATURE METABOLISM (2020)
Genetic deletion of soluble 5′-nucleotidase II reduces body weight gain and insulin resistance induced by a high-fat diet
Manuel Johanns et al.
MOLECULAR GENETICS AND METABOLISM (2019)
AMP-activated protein kinase: the current landscape for drug development
Gregory R. Steinberg et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Mechanisms of action of metformin with special reference to cardiovascular protection
Alexey V. Zilov et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Metformin increases endogenous glucose production in non-diabetic individuals and individuals with recent-onset type 2 diabetes
Lars C. Gormsen et al.
DIABETOLOGIA (2019)
The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances
Pouya Saraei et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Role of Mitochondria in the Mechanism(s) of Action of Metformin
Guillaume Vial et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Mitochondrial targets of metformin-Are they physiologically relevant?
Alena Pecinova et al.
BIOFACTORS (2019)
The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde?
Diana Vara-Ciruelos et al.
OPEN BIOLOGY (2019)
PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis
Xueying Ji et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Glycerol induces G6pc in primary mouse hepatocytes and is the preferred substrate for gluconeogenesis both in vitro and in vivo
Katarzyna M. Kalemba et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity
Zydrune Polianskyte-Prause et al.
FASEB JOURNAL (2019)
Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism
Ahmed Alshawi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
AMPK β1 activation suppresses antipsychotic-induced hyperglycemia in mice
Hesham Shamshoum et al.
FASEB JOURNAL (2019)
Activation of AMPK by Medicinal Plants and Natural Products: Its Role in Type 2 Diabetes Mellitus
Flavio Francini et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2019)
Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD
Daniel Garcia et al.
CELL REPORTS (2019)
Metformin and its anti-inflammatory and anti-oxidative effects; new concepts
Ali Hasanpour Dehkordi et al.
JOURNAL OF RENAL INJURY PREVENTION (2019)
AMPK activation protects against diet-induced obesity through Ucp1-independent thermogenesis in subcutaneous white adipose tissue
Alice E. Pollard et al.
NATURE METABOLISM (2019)
Inhibition of mitochondrial complex I improves glucose metabolism independently of AMPK activation
Wo-Lin Hou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Role of mTOR in Glucose and Lipid Metabolism
Zhuo Mao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Bile acids in glucose metabolism in health and disease
Hagit Shapiro et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Roles of pyruvate carboxylase in human diseases: from diabetes to cancers and infection
Udom Lao-On et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo
Anila K. Madiraju et al.
NATURE MEDICINE (2018)
AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development
Nadia Boudaba et al.
EBIOMEDICINE (2018)
Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
Roger W. Hunter et al.
NATURE MEDICINE (2018)
L-Alanine activates hepatic AMP-activated protein kinase and modulates systemic glucose metabolism
Yusuke Adachi et al.
MOLECULAR METABOLISM (2018)
Effects of metformin mediated by gut microbiota
Claire Greenhill
NATURE REVIEWS ENDOCRINOLOGY (2018)
The Three Ds of Transcription Activation by Glucagon: Direct, Delayed, and Dynamic
Ido Goldstein et al.
ENDOCRINOLOGY (2018)
Structural Determinants for Small-Molecule Activation of Skeletal Muscle AMPK α2β2γ1 by the Glucose Importagog SC4
Kevin R. W. Ngoei et al.
CELL CHEMICAL BIOLOGY (2018)
PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients
Par Steneberg et al.
JCI INSIGHT (2018)
Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL/6J female mice: Role of disturbed lipid homeostasis and increased oxidative stress
Youngshim Choi et al.
FOOD AND CHEMICAL TOXICOLOGY (2017)
Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice
Curtis C. Hughey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy
Robert W. Myers et al.
SCIENCE (2017)
Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet
Angela Woods et al.
CELL REPORTS (2017)
Liver AMP-Activated Protein Kinase Is Unnecessary for Gluconeogenesis but Protects Energy State during Nutrient Deprivation
Clinton M. Hasenour et al.
PLOS ONE (2017)
Glucagon, a key factor in the pathophysiology of type 2 diabetes
Jean Girard
BIOCHIMIE (2017)
The Role of the Gut Microbiota in Bile Acid Metabolism
Oscar Ramirez-Perez et al.
ANNALS OF HEPATOLOGY (2017)
The mechanisms of action of metformin
Graham Rena et al.
DIABETOLOGIA (2017)
Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase
M. Johanns et al.
CELLULAR SIGNALLING (2017)
Effects of genetic deletion of soluble 5′-nucleotidases NT5C1A and NT5C2 on AMPK activation and nucleotide levels in contracting mouse skeletal muscles
Samanta Kviklyte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2017)
AMP-activated protein kinase (AMPK) activator A-769662 increases intracellular calcium and ATP release from astrocytes in an AMPK-independent manner
Julia M. Vlachaki Walker et al.
DIABETES OBESITY & METABOLISM (2017)
Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice
Emily C. Cokorinos et al.
CELL METABOLISM (2017)
Investigation of salicylate hepatic responses in comparison with chemical analogues of the drug
Amy R. Cameron et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Metformin Activates AMPK through the Lysosomal Pathway
Chen-Song Zhang et al.
CELL METABOLISM (2016)
Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin
Emilie Bahne et al.
DIABETES OBESITY & METABOLISM (2016)
Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance
Alejandro Gugliucci
MEDICAL HYPOTHESES (2016)
AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs
D. Grahame Hardie et al.
TRENDS IN CELL BIOLOGY (2016)
AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B
M. Johanns et al.
NATURE COMMUNICATIONS (2016)
Evolving roles of circadian rhythms in liver homeostasis and pathology
Dexi Zhou et al.
ONCOTARGET (2016)
Regulation of AMP-activated protein kinase by natural and synthetic activators
David Grahame Hardie
ACTA PHARMACEUTICA SINICA B (2016)
Regulation and function of AMPK in physiology and diseases
Sang-Min Jeon
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Metformin Action: Concentrations Matter
Ling He et al.
CELL METABOLISM (2015)
Modulation of Glucose Transporter Protein by Dietary Flavonoids in Type 2 Diabetes Mellitus
Fatemeh Hajiaghaalipour et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes
Yumi Itoh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats
Frank A. Duca et al.
NATURE MEDICINE (2015)
Decreased expression of hepatic glucokinase in type 2 diabetes
Rebecca A. Haeusler et al.
MOLECULAR METABOLISM (2015)
Choreography of AMPK activation
Christopher G. Langendorf et al.
CELL RESEARCH (2015)
Metformin Activates AMP-activated Protein Kinase by Promoting Formation of the αβγ Heterotrimeric Complex
Shumei Meng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators
Yu-Chiang Lai et al.
BIOCHEMICAL JOURNAL (2014)
Control of Gluconeogenesis by Metformin: Does Redox Trump Energy Charge?
Joseph A. Baur et al.
CELL METABOLISM (2014)
Effects of Pharmacological AMP Deaminase Inhibition and Ampd1 Deletion on Nucleotide Levels and AMPK Activation in Contracting Skeletal Muscle
Catheline Plaideau et al.
CHEMISTRY & BIOLOGY (2014)
Intestinal glucose metabolism revisited
Gilles Mithieux et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Validation of the Antidiabetic and Hypolipidemic Effects of Clitocybe nuda by Assessment of Glucose Transporter 4 and Gluconeogenesis and AMPK Phosphorylation in Streptozotocin-Induced Mice
Chun-Ching Shih et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK)
Jia Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A Role for Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) in the Regulation of Hepatic Gluconeogenesis
Romana Stark et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPK in Vivo
Clinton M. Hasenour et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju et al.
NATURE (2014)
The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver
Kashyap Patel et al.
NATURE COMMUNICATIONS (2014)
The role of glucagon on type 2 diabetes at a glance
Amelio F. Godoy-Matos
DIABETOLOGY & METABOLIC SYNDROME (2014)
AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net Phosphorylation
Graeme J. Gowans et al.
CELL METABOLISM (2013)
VASP Increases Hepatic Fatty Acid Oxidation by Activating AMPK in Mice
Sanshiro Tateya et al.
DIABETES (2013)
Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5′-monophosphate-activated protein kinase
M. Ikegami et al.
DIABETES OBESITY & METABOLISM (2013)
Molecular mechanism of action of metformin: old or new insights?
Graham Rena et al.
DIABETOLOGIA (2013)
Chemoproteomic Analysis of Intertissue and Interspecies Isoform Diversity of AMP-activated Protein Kinase (AMPK)
Jiang Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats
Christopher R. Lindholm et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2013)
AMPK at the crossroads of circadian clocks and metabolism
Sabine D. Jordan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver
Clinton M. Hasenour et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Russell A. Miller et al.
NATURE (2013)
Hypothalamic Inhibition of Acetyl-CoA Carboxylase Stimulates Hepatic Counter-Regulatory Response Independent of AMPK Activation in Rats
Gustavo A. Santos et al.
PLOS ONE (2013)
Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db/db mice
Yuan-Yuan Li et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Structural basis of AMPK regulation by small molecule activators
Bing Xiao et al.
NATURE COMMUNICATIONS (2013)
Monocarboxylic Acid Transport
Andrew P. Halestrap
COMPREHENSIVE PHYSIOLOGY (2013)
AMP-Activated Protein Kinase: A Target for Drugs both Ancient and Modern
D. Grahame Hardie et al.
CHEMISTRY & BIOLOGY (2012)
Fructose-Induced Hypothalamic AMPK Activation Stimulates Hepatic PEPCK and Gluconeogenesis due to Increased Corticosterone Levels
Andrezza Kinote et al.
ENDOCRINOLOGY (2012)
Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue
X. Julia Xu et al.
JOURNAL OF LIPID RESEARCH (2012)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Simon A. Hawley et al.
SCIENCE (2012)
FoxO transcription factors; Regulation by AKT and 14-3-3 proteins
Guri Tzivion et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
X. Stephenne et al.
DIABETOLOGIA (2011)
Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
Jiangyong Ouyang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Structure of mammalian AMPK and its regulation by ADP
Bing Xiao et al.
NATURE (2011)
AMPK Is a Direct Adenylate Charge-Regulated Protein Kinase
Jonathan S. Oakhill et al.
SCIENCE (2011)
Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice
Y. Fujita et al.
DIABETOLOGIA (2010)
AMPK beta 1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin Resistance
Nicolas Dzamko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Whole Body Deletion of AMP-activated Protein Kinase β2 Reduces Muscle AMPK Activity and Exercise Capacity
Gregory R. Steinberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
AMPK-Dependent Metabolic Regulation by PPAR Agonists
Woo Hyung Lee et al.
PPAR RESEARCH (2010)
AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives
B. Viollet et al.
ACTA PHYSIOLOGICA (2009)
AMP-activated protein kinase activator A-769662 is an inhibitor of the Na+-K+-ATPase
Boubacar Benziane et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
The Randle cycle revisited: a new head for an old hat
Louis Hue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Activation of SIRT1 by Resveratrol Represses Transcription of the Gene for the Cytosolic Form of Phosphoenolpyruvate Carboxykinase (GTP) by Deacetylating Hepatic Nuclear Factor 4α
Jianqi Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Association of AMP-activated Protein Kinase Subunits With Glycogen Particles as Revealed In Situ by Immunoelectron Microscopy
Moise Bendayan et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Carles Canto et al.
NATURE (2009)
Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase
Mohammed H. Mukhtar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Thienopyridone Drugs Are Selective Activators of AMP-Activated Protein Kinase β1-Containing Complexes
John W. Scott et al.
CHEMISTRY & BIOLOGY (2008)
Efficacy of berberine in patients with type 2 diabetes mellitus
Jun Yin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP
Yong Deuk Kim et al.
DIABETES (2008)
Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase
Olga Goeransson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family
Matthew J. Sanders et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2
Renaud Dentin et al.
NATURE (2007)
Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues
Nathan K. LeBrasseur et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
Liver adenosine monophosphate-activated kinase-α2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin
F Andreelli et al.
ENDOCRINOLOGY (2006)
5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation
B Guigas et al.
DIABETES (2006)
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review
A Natali et al.
DIABETOLOGIA (2006)
Energy state of the liver during short-term and exhaustive exercise in C57BL/6J mice
RC Camacho et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
SH Koo et al.
NATURE (2005)
Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver
M Foretz et al.
DIABETES (2005)
AMP-activated protein kinase plays a role in the control of food intake
U Andersson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Activation of glycogen phosphorylase with 5-aminoimidazole-4-carboxamide riboside (AICAR) - Assessment of glycogen as a precursor of mannosyl residues in glycoconjugates
J Shang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The transcription factors HIF-1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the phosphatidylinositol 3-kinase/protein kinase B pathway
U Roth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Knockout of the α2 but not α1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside- but not contraction-induced glucose uptake in skeletal muscle
SB Jorgensen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes
M Krssak et al.
DIABETES (2004)
Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition
X Yu et al.
DIABETOLOGIA (2004)
Impact of metformin on glucose metabolism in nondiabetic, obese African Americans - A placebo-controlled, 24-month randomized study
D Schuster et al.
DIABETES CARE (2004)
Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression
R Dentin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
AMP-activated protein kinase regulates HNF4α transcriptional activity by inhibiting dimer formation and decreasing protein stability
YH Hong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation
PX She et al.
DIABETES (2003)
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
T Yamauchi et al.
NATURE MEDICINE (2002)
Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise
H Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Y Minokoshi et al.
NATURE (2002)
Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein
T Kawaguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Calculation of relative binding free energy differences for fructose 1,6-bisphosphatase inhibitors using the thermodynamic cycle perturbation approach
MR Reddy et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Mechanism by which metformin reduces glucose production in type 2 diabetes
RS Hundal et al.
DIABETES (2000)
5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase
PA Lochhead et al.
DIABETES (2000)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
